Research suggests that bromelain, particularly in combination with N-acetylcysteine, may have properties relevant to post-surgical recovery contexts such as reducing inflammation and breaking down thick tissue secretions, though the available evidence linking it directly to post-surgery recovery is very limited. The single identified study examined BromAc, a bromelain-NAC combination, in a laboratory setting using mucus samples from critically ill COVID-19 patients rather than surgical patients, finding that the combination effectively thinned mucus and reduced pro-inflammatory signaling molecules including IL-6 and MCP-1. This was a lab-based study on collected samples, not a clinical trial, which significantly limits the conclusions that can be drawn about real-world outcomes in post-surgical populations. Studies in this area are sparse and largely indirect, so readers should be cautious about drawing firm conclusions regarding bromelain's role in post-surgery recovery based on currently linked evidence.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspira... | Other | 2021 | Neutral | 90 |